CatalentCDMO · Catalent访问官网 →免费展示 · 资料来自公开信息 · 如需撤下请联系 ads@biotechuni.comBiotechUni — International Biotech Community / 国际生物科技社区
国际生物科技社区 · Industry, R&D pipeline, funding & applications — industry trends, public R&D pipelines, funding notes, compliant applications & CRO/CDMO/tools. Bilingual CN+EN. Independent biotech industry community (complementary to DnaUni consumer DNA literacy). Not medical advice or diagnosis. No lab how-tos / pathogen enhancement. No politics.
CategoriesPick a board and join the discussion
Announcements / 站务公告
Forum news, bilingual rules, and official notices
Latest: 【招商】广告位刊例与首单优惠 / Advertise on BiotechUni
2026-10-24 09:00 北京时间
2026-10-24 09:00 北京时间
3 threads
3 posts
3 posts
Industry / 产业与政策环境
Public policy & industry environment notes — not legal advice
Latest: 产业地图怎么画:环节、区域与证据 / Industry map fields
2026-10-26 17:33 北京时间
2026-10-26 17:33 北京时间
6 threads
6 posts
6 posts
R&D Pipeline / 研发管线(公开信息)
Public pipeline reading fields — not lab instruction
Latest: 读懂公开终点指标:别写成疗效承诺 / Reading public endpoints
2026-10-26 21:33 北京时间
2026-10-26 21:33 北京时间
7 threads
7 posts
7 posts
Funding / 投融资
Public rounds & diligence fields — not investment advice
Latest: 条款速读:优先股/里程碑/选择权(公开摘要) / Term sheet public notes
2026-10-27 00:33 北京时间
2026-10-27 00:33 北京时间
6 threads
6 posts
6 posts
Applications / 应用落地
Compliant application cases — not diagnosis
Latest: 真实世界证据(公开)怎么引用 / Citing public RWE
2026-10-27 03:33 北京时间
2026-10-27 03:33 北京时间
6 threads
6 posts
6 posts
Services & Tools / CRO·CDMO·工具
Compare CRO/CDMO/tools from public info
Latest: 供应商问卷(公开信息)模板 / Vendor questionnaire template
2026-10-27 07:33 北京时间
2026-10-27 07:33 北京时间
7 threads
7 posts
7 posts
Chinese / 中文交流
Chinese-first general biotech industry talk
Latest: 中文交流:本周想讨论的产业话题征集 / CN weekly topic call
2026-10-27 08:33 北京时间
2026-10-27 08:33 北京时间
2 threads
2 posts
2 posts
Latest activityAll threads →
0 replies
18 views
18 views
0 replies
14 views
14 views
0 replies
6 views
6 views
0 replies
7 views
7 views
0 replies
7 views
7 views
0 replies
6 views
6 views
0 replies
8 views
8 views
0 replies
10 views
10 views
0 replies
7 views
7 views
0 replies
9 views
9 views
0 replies
7 views
7 views
0 replies
10 views
10 views
0 replies
6 views
6 views
0 replies
8 views
8 views
0 replies
8 views
8 views
0 replies
8 views
8 views
0 replies
8 views
8 views
0 replies
8 views
8 views
0 replies
7 views
7 views
0 replies
7 views
7 views
0 replies
16 views
16 views
0 replies
16 views
16 views
0 replies
19 views
19 views
0 replies
14 views
14 views
